ArticleJournal of virology2025

A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates.

Ashley C Beavis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.